Extracellular Purines in Endothelial Cell Barrier Regulation - Extracellular ATP and Adenosine as Regulators of Endothelial Cell Function - page 49

24. da Silva CG, Specht A, Wegiel B, Ferran C, Kaczmarek E. (2009) Mechanism of purinergic
activation of endothelial nitric oxide synthase in endothelial cells. Circulation 119:871-9.
25. Dedkova EN, Blatter LA. (2002) Nitric oxide inhibits capacitative Ca 2+ entry and
enhances endoplasmic reticulum Ca 2+ uptake in bovine vascular endothelial cells. J Physiol
539:77-91.
26. Di Benedetto G, Zoccarato A, Lissandron V, Terrin A, Li X, Houslay MD, Baillie GS,
Zaccolo M. (2008) Protein kinase A type I and type II define distinct intracellular signaling
compartments. Circ Res 103:836-44.
27. Dudek SM, Camp SM, Chiang ET, Singleton PA, Usatyuk PV, Zhao Y, Natarajan V,
Garcia JG. (2007) Pulmonary endothelial cell barrier enhancement by FTY720 does not
require the S1P1 receptor. Cell Signal 19:1754-64.
28. Dudek SM, Garcia JG. (2001) Cytoskeletal regulation of pulmonary vascular permeability.
J Appl Physiol 91:1487-500.
29. Duza T, Sarelius IH. (2003) Conducted dilations initiated by purines in arterioles are
endothelium dependent and require endothelial Ca 2+ .AmJPhysiolHeartCircPhysiol
285:H26-37.
30. Ecke D, Hanck T, Tulapurkar ME, Schafer R, Kassack M, Stricker R, Reiser G. (2008)
Hetero-oligomerization of the P2Y11 receptor with the P2Y1 receptor controls the internal-
ization and ligand selectivity of the P2Y11 receptor. Biochem J 409:107-16.
31. Eckle T, Faigle M, Grenz A, Laucher S, Thompson LF, Eltzschig HK. (2008) A2B adenosine
receptor dampens hypoxia-induced vascular leak. Blood 111:2024-35.
32. Eltzschig HK, Abdulla P, Hoffman E, Hamilton KE, Daniels D, Schonfeld C, Loffler M,
Reyes G, Duszenko M, Karhausen J, Robinson A, Westerman KA, Coe IR, Colgan SP.
(2005) HIF-1-dependent repression of equilibrative nucleoside transporter (ENT) in

hypoxia. J Exp Med 202:1493-505.
33. Eltzschig HK, Faigle M, Knapp S, Karhausen J, Ibla J, Rosenberger P, Odegard KC,
Laussen PC, Thompson LF, Colgan SP. (2006) Endothelial catabolism of extracellular
adenosine during hypoxia: the role of surface adenosine deaminase and CD26. Blood
108:1602-10.
34. Erlinge D. (2004) Extracellular ATP: a central player in the regulation of vascular
smooth muscle phenotype. Focus on “Dual role of PKA in phenotype modulation of
vascular smooth muscle cells by extracellular ATP”. Am J Physiol Cell Physiol 287:
C260-2.
35. Fang Y, Olah ME. (2007) Cyclic AMP-dependent, protein kinase A-independent activa-
tion of extracellular signal-regulated kinase 1/2 following adenosine receptor stimulation
in human umbilical vein endothelial cells: role of exchange protein activated by cAMP 1
(Epac1). J Pharmacol Exp Ther 322:1189-200.
36. Filippov AK, Fernandez-Fernandez JM, Marsh SJ, Simon J, Barnard EA, Brown DA. (2004)
Activation and inhibition of neuronal G protein-gated inwardly rectifying K(+) channels by
P2Y nucleotide receptors. Mol Pharmacol 66:468-77.
37. Filippov AK, Webb TE, Barnard EA, Brown DA. (1999) Dual coupling of heterologously-
expressed rat P2Y6 nucleotide receptors to N-type Ca 2+

and M-type K +

currents in rat

sympathetic neurones. Br J Pharmacol 126:1009-17.
38. Fleming I, Fisslthaler B, Dimmeler S, Kemp BE, Busse R. (2001) Phosphorylation of
Thr(495) regulates Ca(2+)/calmodulin-dependent endothelial nitric oxide synthase activity.
Circ Res 88:E68-75.
39. Fukuhara S, Sakurai A, Sano H, Yamagishi A, Somekawa S, Takakura N, Saito Y,
Kangawa K, Mochizuki N. (2005) Cyclic AMP potentiates vascular endothelial cadherin-
mediated cell-cell contact to enhance endothelial barrier function through an Epac-Rap1
signaling pathway. Mol Cell Biol 25:136-46.
40. Garcia JG, Davis HW, Patterson CE. (1995) Regulation of endothelial cell gap formation
and barrier dysfunction: role of myosin light chain phosphorylation. J Cell Physiol 163:
510-22.